Africa: U.S. Drug Company Eases Access to Multidrug-Resistant Tuberculosis Treatment

[JNJ] Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: underdiagnosis of the disease.

Original URL: Click here to visit original article